Ignite Creation Date:
2024-05-06 @ 4:21 PM
Last Modification Date:
2024-10-26 @ 2:08 PM
Study NCT ID:
NCT04950504
Status:
TERMINATED
Last Update Posted:
2023-09-18
First Post:
2021-06-03
Brief Title:
Evaluate the Safety Tolerability Pharmacodynamics and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy
Sponsor:
Organization:
COUR Pharmaceutical Development Company Inc
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
9
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
Observational Models:
Time Perspective List:
Who Masked List: